Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Goodkin

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Brain and Cognition|September 1, 1989
Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosisW W Beatty, D E Goodkin, P A Beatty, et al.
Archives of Neurology|October 1, 1989
Cognitive disturbances in patients with relapsing remitting multiple sclerosisW W Beatty, D E Goodkin, N Monson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
Depression, coping and level of neurological impairment in multiple sclerosisD C Mohr, D E Goodkin, N Gatto, et al.
Neurology|February 1, 1996
Side effect profile of interferon beta-1b in MS: results of an open label trialL K Neilley, D S Goodin, D E Goodkin, et al.
Applied Nursing Research : ANR|May 1, 1996
Relationships among illness uncertainty, stress, coping, and emotional well-being at entry into a clinical drug trialN M Wineman, K M Schwetz, D E Goodkin, et al.
Archives of Neurology|August 1, 1987
Cyclophosphamide in chronic progressive multiple sclerosis. Maintenance vs nonmaintenance therapyD E Goodkin, S Plencner, J Palmer-Saxerud, et al.
Archives of Neurology|June 1, 1988
Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosisW W Beatty, D E Goodkin, N Monson, et al.
Journal of Consulting and Clinical Psychology|January 5, 2002
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosisD C Mohr, A C Boudewyn, D E Goodkin, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 8, 2001
Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-injectD C Mohr, A C Boudewyn, W Likosky, et al.
Neurology|January 1, 1991
The efficacy of azathioprine in relapsing-remitting multiple sclerosisD E Goodkin, R C Bailly, M L Teetzen, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Brain and Cognition|September 1, 1989
Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosisW W Beatty, D E Goodkin, P A Beatty, et al.
Archives of Neurology|October 1, 1989
Cognitive disturbances in patients with relapsing remitting multiple sclerosisW W Beatty, D E Goodkin, N Monson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
Depression, coping and level of neurological impairment in multiple sclerosisD C Mohr, D E Goodkin, N Gatto, et al.
Neurology|February 1, 1996
Side effect profile of interferon beta-1b in MS: results of an open label trialL K Neilley, D S Goodin, D E Goodkin, et al.
Applied Nursing Research : ANR|May 1, 1996
Relationships among illness uncertainty, stress, coping, and emotional well-being at entry into a clinical drug trialN M Wineman, K M Schwetz, D E Goodkin, et al.
Archives of Neurology|August 1, 1987
Cyclophosphamide in chronic progressive multiple sclerosis. Maintenance vs nonmaintenance therapyD E Goodkin, S Plencner, J Palmer-Saxerud, et al.
Archives of Neurology|June 1, 1988
Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosisW W Beatty, D E Goodkin, N Monson, et al.
Journal of Consulting and Clinical Psychology|January 5, 2002
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosisD C Mohr, A C Boudewyn, D E Goodkin, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 8, 2001
Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-injectD C Mohr, A C Boudewyn, W Likosky, et al.
Neurology|January 1, 1991
The efficacy of azathioprine in relapsing-remitting multiple sclerosisD E Goodkin, R C Bailly, M L Teetzen, et al.
Pageof 9